Cited 18 time in
Modeling of Autism Using Organoid Technology
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Choi, Hwan | - |
| dc.contributor.author | Song, Juhyun | - |
| dc.contributor.author | Park, Guiyeon | - |
| dc.contributor.author | Kim, Jongpil | - |
| dc.date.accessioned | 2024-08-08T01:01:57Z | - |
| dc.date.available | 2024-08-08T01:01:57Z | - |
| dc.date.issued | 2017-12 | - |
| dc.identifier.issn | 0893-7648 | - |
| dc.identifier.issn | 1559-1182 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/14815 | - |
| dc.description.abstract | Autism is a neurodevelopmental disease caused by multiple mutations during development. However, a suitable disease model to study the molecular pathway of disease onset and progression is not available. Although many studies have used human stem cells such as induced pluripotent stem cells and embryonic stem cells to investigate the disease pathogenesis, these stem cell techniques are limited in their abilities to study the pathology and mechanism of pathogenesis of neurodevelopmental diseases such as autism. Therefore, researchers are focusing on the strengths of three-dimensional (3D) structures mimicking organs, organoids, for modeling autism. In this review, we highlight the advantages of 3D organoid systems to investigate the mechanisms of the pathogenesis of autism. Further, because the onset of autism is determined by genetic background, we suggest the application of the clustered regularly interspersed short palindromic repeat-associated protein 9 (CRISPR/Cas9) technique for genome editing in 3D organoid systems to study mutations that cause autism. We propose that 3D organoid systems combined with the CRISPR/Cas9 technique may advance autism research. | - |
| dc.format.extent | 7 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | SPRINGER | - |
| dc.title | Modeling of Autism Using Organoid Technology | - |
| dc.type | Article | - |
| dc.publisher.location | 미국 | - |
| dc.identifier.doi | 10.1007/s12035-016-0274-8 | - |
| dc.identifier.scopusid | 2-s2.0-84995444927 | - |
| dc.identifier.wosid | 000415341900019 | - |
| dc.identifier.bibliographicCitation | MOLECULAR NEUROBIOLOGY, v.54, no.10, pp 7789 - 7795 | - |
| dc.citation.title | MOLECULAR NEUROBIOLOGY | - |
| dc.citation.volume | 54 | - |
| dc.citation.number | 10 | - |
| dc.citation.startPage | 7789 | - |
| dc.citation.endPage | 7795 | - |
| dc.type.docType | Review | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Neurosciences & Neurology | - |
| dc.relation.journalWebOfScienceCategory | Neurosciences | - |
| dc.subject.keywordPlus | PLURIPOTENT STEM-CELLS | - |
| dc.subject.keywordPlus | GENOME-WIDE ASSOCIATION | - |
| dc.subject.keywordPlus | FAMILY-BASED ASSOCIATION | - |
| dc.subject.keywordPlus | IN-VITRO MODEL | - |
| dc.subject.keywordPlus | SPECTRUM DISORDERS | - |
| dc.subject.keywordPlus | DIRECTED DIFFERENTIATION | - |
| dc.subject.keywordPlus | 3-DIMENSIONAL CULTURE | - |
| dc.subject.keywordPlus | CEREBRAL ORGANOIDS | - |
| dc.subject.keywordPlus | CRISPR-CAS9 SYSTEM | - |
| dc.subject.keywordPlus | EXTRINSIC SIGNALS | - |
| dc.subject.keywordAuthor | Autism | - |
| dc.subject.keywordAuthor | Organoids | - |
| dc.subject.keywordAuthor | Induced pluripotent stem cells (iPSCs) | - |
| dc.subject.keywordAuthor | Clustered regularly interspersed short palindromic repeat-associated protein 9 (CRISPR/Cas9) | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
